Attenuated and nonproductive viral transcription in the lymphatic tissue of HIV-1-infected patients receiving potent antiretroviral therapy

被引:37
作者
Fischer, M
Joos, B
Wong, JK
Ott, P
Opravil, M
Hirschel, B
Weber, R
Günthard, HF
机构
[1] Univ Zurich Hosp, Dept Med, Div Infect Dis & Hosp Epidemiol, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Clin Ear Nose & Throat Surg, CH-8091 Zurich, Switzerland
[3] Univ Hosp Geneva, Div Infect Dis, Geneva, Switzerland
[4] Univ Calif San Diego, San Diego Vet Affairs Healthcare Syst, San Diego, CA 92103 USA
关键词
D O I
10.1086/380797
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human immunodeficiency virus type 1 (HIV-1) RNA that persists in the lymphoid tissue of patients despite treatment with highly active antiretroviral therapy (HAART) may represent extracellular virions or intracellular RNAs residing within HIV-infected cells. To further characterize residual viral transcription, tonsil biopsy specimens from patients receiving long-term HAART, untreated patients, and patients undergoing 2 weeks of structured treatment interruption were analyzed by polymerase chain reaction quantification of virion-encapsidated RNA, intracellular unspliced HIV RNA (HIV UsRNA), multiply spliced HIV RNA encoding tat and rev (HIV MsRNA), and HIV DNA. Tonsil biopsy specimens from viremic patients harbored high amounts of virions, which primarily stemmed from local production, as indicated by a strong correlation of extracellular tonsillar RNA with intracellular HIV-1 nucleic acid levels but not with plasma viremia, and as shown by phylogenetic analysis of clonal env sequences from lymphoid tissue and plasma. In patients receiving HAART, intracellular HIV UsRNA persisted at significantly decreased levels, whereas HIV MsRNA and lymphoid virion levels were depleted. Thus, residual lymphoid HIV-1 RNA in patients receiving HAART indicates attenuated viral transcription in HIV-1-infected cells that lack virion production.
引用
收藏
页码:273 / 285
页数:13
相关论文
共 56 条
[1]  
AUSUBEL SM, 1987, CURRENT PROTOCOLS MO
[2]   Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo [J].
Bagnarelli, P ;
Valenza, A ;
Menzo, S ;
Sampaolesi, R ;
Varaldo, PE ;
Butini, L ;
Montroni, M ;
Perno, CF ;
Aquaro, S ;
Mathez, D ;
Leibowitch, J ;
Balotta, C ;
Clementi, M .
JOURNAL OF VIROLOGY, 1996, 70 (11) :7603-7613
[3]   The challenge of viral reservoirs in HIV-1 infection [J].
Blankson, JN ;
Persaud, D ;
Siliciano, RF .
ANNUAL REVIEW OF MEDICINE, 2002, 53 :557-593
[4]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA EXPRESSION BY 4 CHRONICALLY INFECTED CELL-LINES INDICATES MULTIPLE MECHANISMS OF LATENCY [J].
BUTERA, ST ;
ROBERTS, BD ;
LAM, L ;
HODGE, T ;
FOLKS, TM .
JOURNAL OF VIROLOGY, 1994, 68 (04) :2726-2730
[5]   Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection [J].
Cavert, W ;
Notermans, DW ;
Staskus, K ;
Wietgrefe, SW ;
Zupancic, M ;
Gebhard, K ;
Henry, K ;
Zhang, ZQ ;
Mills, R ;
McDade, H ;
Goudsmit, J ;
Danner, SA ;
Haase, AT .
SCIENCE, 1997, 276 (5314) :960-964
[6]   PCR-based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells [J].
Christopherson, C ;
Kidane, Y ;
Conway, B ;
Krowka, J ;
Sheppard, H ;
Kwok, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (02) :630-634
[7]   Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy [J].
Chun, TW ;
Davey, RT ;
Ostrowski, M ;
Justement, JS ;
Engel, D ;
Mullins, JI ;
Fauci, AS .
NATURE MEDICINE, 2000, 6 (07) :757-761
[8]  
ERCOLANI L, 1988, J BIOL CHEM, V263, P15335
[9]   A prospective trial of structured treatment interruptions in human immunodeficiency virus infection [J].
Fagard, C ;
Oxenius, A ;
Günthard, H ;
Garcia, F ;
Le Braz, M ;
Mestre, G ;
Battegay, M ;
Furrer, H ;
Vernazza, P ;
Bernasconi, E ;
Telenti, A ;
Weber, R ;
Leduc, D ;
Yerly, S ;
Price, D ;
Dawson, SJ ;
Klimkait, T ;
Perneger, TV ;
McLean, A ;
Clotet, B ;
Gatell, JM ;
Perrin, L ;
Plana, M ;
Phillips, R ;
Hirschel, B .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (10) :1220-1226
[10]   HTLV-III EXPRESSION AND PRODUCTION INVOLVE COMPLEX REGULATION AT THE LEVELS OF SPLICING AND TRANSLATION OF VIRAL-RNA [J].
FEINBERG, MB ;
JARRETT, RF ;
ALDOVINI, A ;
GALLO, RC ;
WONGSTAAL, F .
CELL, 1986, 46 (06) :807-817